Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for episodic paroxysmal hemicrania in children
IRCT20190208042654N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cyproheptadine in paroxysmal hemicrania (PH), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Headache severity, Headache duration and 1 more. Started Apr 2022; status: completed.
02
Drugs
cyproheptadine
03
Conditions
paroxysmal hemicrania (PH)
Beyond the preview
Go deeper on IRCT20190208042654N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190208042654N5.